During the past 4 months, medicine throughout the world has been challenged on how COVID-19 impacts our body and how best to treat it.
This observational study adds more information. Further study is needed to determine whether or not this is medically relevant.
https://www.jaad.org/article/S0190-9622(2)30948-8/pdf
You Might Also Enjoy...
These are the first two CME articles on hair transplantation to ever be published in the leading peer reviewed journal in our field. I am proud to be one of its authors.
During the American Academy of Dermatology (AAD) virtual meeting experience, I was happy to participate in this very informative session on innovative therapeutic tools to slow hair loss and increase hair growth.
JAK inhibitors approved now by the FDA represent an important new treatment option for our patients with widespread alopecia areata.
More promising news in the treatment of alopecia areata. More clinical trials are needed to ensure safety and efficacy but very promising.
This analysis demonstrates that there is no increased risk of cancer when using spironolactone.
For some highly motivated patients, a combination of two therapies can be effective in helping hair loss.
